CN1095283A - " Sancao " medicine powder for hepatitis B - Google Patents
" Sancao " medicine powder for hepatitis B Download PDFInfo
- Publication number
- CN1095283A CN1095283A CN 93106000 CN93106000A CN1095283A CN 1095283 A CN1095283 A CN 1095283A CN 93106000 CN93106000 CN 93106000 CN 93106000 A CN93106000 A CN 93106000A CN 1095283 A CN1095283 A CN 1095283A
- Authority
- CN
- China
- Prior art keywords
- radix
- hepatitis
- medicine
- effect
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
" Sancao " medicine powder for hepatitis B belongs to Chinese patent medicine, is made up of Herba Artemisiae Scopariae, Radix Scutellariae, Radix Bupleuri, Radix Glycyrrhizae, Spica Prunellae, blue root, the Radix Astragali, Radix Angelicae Sinensis, Radix Gentianae, Herba Taraxaci, Fructus Schisandrae Chinensis, Rhizoma Coptidis, the Radix Rehmanniae, the Radix Paeoniae Alba.Chinese patent medicine of the present invention has the pharmacological action of anti-hepatitis virus, improve the effect of HBSAg negative conversion rate, protect the liver, make the transaminase to recover normal effect, also has the enhancing human body immunity function, the effect of strengthening vital QI to eliminate pathogenic factors and prophylactic treatment hepatocellular damage, the effective percentage of treatment hepatitis B is 97.1%, non-relapse after healing.
Description
" Sancao " medicine powder for hepatitis B belongs to Chinese patent medicine.
The routine administration of the hepatitis of China's treatment now belongs to symptomatic treatment, and as glucose, hepatoprotective etc., its clinical effectiveness is not good.At present international and domestic applied anti-hepatitis virus medicine high specificity does not possess protecting the liver, falls enzyme, regulates the function that immunity improves general body state, and the not strong medicine of specificity, and as interferon etc., its clinical effectiveness is not good again.The conventional Chinese medicine determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs can improve the clinical symptoms function, can reduce HBSAg, fall enzyme, but every kind of single and normal easily recurrence of drug effect mainly is that present medicine lacks the cause of disease and Comprehensive Treatment effect.
The objective of the invention is to develop and a kind ofly have anti-hepatitis virus, improve the HBSAg negative conversion rate, protect the liver, make the transaminase to recover to treat normally the Chinese patent medicine of hepatitis B.
The present invention is made up of Herba Artemisiae Scopariae, Radix Scutellariae, Radix Bupleuri, Radix Glycyrrhizae, Spica Prunellae, Cymbidium ensifolium (L.) Sw. root, the Radix Astragali, Radix Angelicae Sinensis, Radix Gentianae, Herba Taraxaci, Fructus Schisandrae Chinensis, Rhizoma Coptidis, the Radix Rehmanniae, Radix Paeoniae Alba composition.Every by weight flavor medicine accounts for: Herba Artemisiae Scopariae 12～13%, Radix Scutellariae 7.3～8.3%, Radix Bupleuri 4.2～5.2%, Radix Glycyrrhizae 8.9～9.9%, Spica Prunellae 7.3～8.3%, Cymbidium ensifolium (L.) Sw. root 4.2～5.2%, the Radix Astragali 7.3～8.3%, Radix Angelicae Sinensis 4.2～5.2%, Radix Gentianae 5.7～6.7%, Herba Taraxaci 8.9～9.9%, Fructus Schisandrae Chinensis 4.2～5.2%, Rhizoma Coptidis 5.8～6.8%, the Radix Rehmanniae 4.2～5.2%, the Radix Paeoniae Alba 8.9～9.9%.
The Chinese patent medicine that the present invention treats hepatitis B has the pharmacological action of anti-hepatitis virus, has the effect that improves the HBSAg negative conversion rate, protect the liver, make the transaminase to recover normal effect, also have the effect of enhancing human body immunity function, strengthening vital QI to eliminate pathogenic factors and prophylactic treatment hepatocellular damage.The effective percentage of taking this medicine treatment hepatitis B is 97.1%, non-relapse after healing.
Embodiment: select Herba Artemisiae Scopariae 12.5%, Radix Scutellariae 7.8%, Radix Bupleuri 4.7%, Radix Glycyrrhizae 9.4%, Spica Prunellae 7.8%, Cymbidium ensifolium (L.) Sw. root 4.7%, the Radix Astragali 7.8%, Radix Angelicae Sinensis 4.7%, Radix Gentianae 6.2%, Herba Taraxaci 9.4%, Fructus Schisandrae Chinensis 4.7%, Rhizoma Coptidis 6.3%, the Radix Rehmanniae 4.7%, the Radix Paeoniae Alba 9.4% by weight.Above-mentioned 14 flavor medicines are pulverized, crossed sieve No. 5, existing through cobalt 60 sterilizations 30 minutes again.
Claims (1)
1, " Sancao " medicine powder for hepatitis B belongs to Chinese patent medicine, it is characterized in that this medicine is made up of following composition and weight: Herba Artemisiae Scopariae 12～13%, Radix Scutellariae 7.3～8.3%, Radix Bupleuri 4.2～5.2%, Radix Glycyrrhizae 8.9～9.9%, Spica Prunellae 7.3～8.3%, Cymbidium ensifolium (L.) Sw. root 4.2～5.2%, the Radix Astragali 7.3～8.3%, Radix Angelicae Sinensis 4.2～5.2%, Radix Gentianae 5.7～6.7%, Herba Taraxaci 8.9～9.9%, Fructus Schisandrae Chinensis 4.2～5.2%, Rhizoma Coptidis 5.8～6.8%, the Radix Rehmanniae 4.2～5.2%, the Radix Paeoniae Alba 8.9～9.9%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93106000A CN1045387C (en) | 1993-05-20 | 1993-05-20 | "Sancao" medicine powder for hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93106000A CN1045387C (en) | 1993-05-20 | 1993-05-20 | "Sancao" medicine powder for hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1095283A true CN1095283A (en) | 1994-11-23 |
| CN1045387C CN1045387C (en) | 1999-10-06 |
Family
ID=4986028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93106000A Expired - Fee Related CN1045387C (en) | 1993-05-20 | 1993-05-20 | "Sancao" medicine powder for hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1045387C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998001144A1 (en) * | 1996-07-09 | 1998-01-15 | Sage R & D | Antiviral agents from plant extracts and use for treatment of viral infections |
| CN1857687B (en) * | 2006-04-03 | 2010-06-16 | 韩传林 | Hepatitis B treating Chinese herbal medicine |
| CN101623374B (en) * | 2009-08-10 | 2011-08-10 | 赵土荣 | Hepatopathy rehabilitation soup |
| CN104398961A (en) * | 2014-11-27 | 2015-03-11 | 王利华 | Traditional Chinese medicine preparation for treating viral hepatitis |
| CN107362329A (en) * | 2017-07-20 | 2017-11-21 | 闫鹏生 | A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy |
| CN108607082A (en) * | 2016-12-12 | 2018-10-02 | 董早霞 | The careless preparation of the five tastes five |
-
1993
- 1993-05-20 CN CN93106000A patent/CN1045387C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998001144A1 (en) * | 1996-07-09 | 1998-01-15 | Sage R & D | Antiviral agents from plant extracts and use for treatment of viral infections |
| CN1857687B (en) * | 2006-04-03 | 2010-06-16 | 韩传林 | Hepatitis B treating Chinese herbal medicine |
| CN101623374B (en) * | 2009-08-10 | 2011-08-10 | 赵土荣 | Hepatopathy rehabilitation soup |
| CN104398961A (en) * | 2014-11-27 | 2015-03-11 | 王利华 | Traditional Chinese medicine preparation for treating viral hepatitis |
| CN108607082A (en) * | 2016-12-12 | 2018-10-02 | 董早霞 | The careless preparation of the five tastes five |
| CN107362329A (en) * | 2017-07-20 | 2017-11-21 | 闫鹏生 | A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1045387C (en) | 1999-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1044974C (en) | Anti- hepatitis B preparation | |
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN103356923A (en) | Detoxification strengthening powder for treating chronic viral hepatitis B | |
| CN1145240A (en) | Medicinal compsn. for prevention of Aids virus and cancer | |
| CN1178675C (en) | Toxin-discharging liver-fortifying medicine | |
| CN1045387C (en) | "Sancao" medicine powder for hepatitis B | |
| CN1593571A (en) | Chinese traditional medicine for treating hypertension | |
| CN1100642A (en) | Chinese medicine preparation for treating viral hepatitis B | |
| CN1903321A (en) | Traditional Chinese medicine pills for prolonging life and consolidating vital essential | |
| CN1824168A (en) | Sancaoyigan powdar preparation for treating hepatitis B | |
| CN101912524A (en) | Schisandra liver-benefiting capsules | |
| CN101461857B (en) | Medicament for treating severe hepatitis | |
| CN1224413C (en) | Chinese medicine granule preparation for curing stomatocace | |
| CN1331996A (en) | Hepatitis B treaitng pill | |
| CN1053825C (en) | Wuling C-hepatitis powder | |
| CN1058911A (en) | The compound method of capsule for curing tumour | |
| CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
| CN1169570C (en) | Medicine for treating acute and chronic hepatitis B | |
| CN1393255A (en) | Medicine for treating viral hepatitis C | |
| CN102949658B (en) | Drug formula for treating hepatitis | |
| CN1146362A (en) | Capsule for anti hepatitis B | |
| CN1086141C (en) | Medicine for treating early-stage hepatocirrhosis and its preparation | |
| CN1102591A (en) | Three-seedling compound mixture and formula thereof | |
| CN107551182A (en) | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder | |
| CN1943682A (en) | A Chinese traditional medicinal composition for treatment of hepatitis C |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |